Pharmaceutical Key Trends 2011 Prescription Pharmaceutical Sales Overview

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Nov 2014

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • November 2014
  • 133 pages

BMI View: We commend initiatives launched by Singapore's government to ease the financial burden of healthcare on lower-income patients. However, the limited number of hospital beds and disproportionately high private healthcare expenditure will continue to put pressure on patients. BMI believes Singapore's ...

Industries: Drug and Medication | Countries: Singapore

Oncogenex Pharmaceuticals, Incorporation

Oncogenex Pharmaceuticals, Incorporation

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 54 pages

A textual analysis of the financial results for Oncogenex Pharmaceuticals, Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical

Pacira Pharmaceuticals Inc

Pacira Pharmaceuticals Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 55 pages

A textual analysis of the financial results for Pacira Pharmaceuticals Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Pharmaceutical

Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd.

Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 56 pages

A textual analysis of the financial results for Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and ...

Industries: Pharmaceutical

Amicus Therapeutics, Inc

Amicus Therapeutics, Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 56 pages

A textual analysis of the financial results for Amicus Therapeutics, Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy

Aoxing Pharmaceutical Company, Incorporation

Aoxing Pharmaceutical Company, Incorporation

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 55 pages

A textual analysis of the financial results for Aoxing Pharmaceutical Company, Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security ...

Industries: Pharmaceutical

Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 56 pages

A textual analysis of the financial results for Cyclacel Pharmaceuticals, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Pharmaceutical

Pain Therapeutics, Inc., Wright Investors' Service

Pain Therapeutics, Inc., Wright Investors' Service

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 56 pages

A textual analysis of the financial results for Pain Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Therapy

Argentina Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

Argentina Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • November 2014
  • 135 pages

Argentina joined the wide swathe of Latin American countries reporting very solid Q110 real Gross Domestic Product growth figures, with the economy grow ing 6.8% year-on-year (y-o-y) according to official data. This marks the fastest expansion since the final months of the pre-crisis boom in Q308, and ...

Industries: Drug and Medication | Countries: Argentina

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.